Innospec Inc. (IOSP) stock
IOSPNasdaqChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3015% below fair value
$78.86+0.85 (+1.09%)
Close on Nov 18, 2026Market cap $1.94BP/E –Yield 2.17%
Innospec revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Innospec's revenue for the twelve months ending Jun 30, 2026 was $1.84B, up 2.9% year over year. For fiscal 2025 it was $1.78B, down 3.7% from the year before. Over ten years it grew 5.8% a year on average. The highest annual figure on record is $1.96B in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.78B | -3.7% |
| FY2024 | Dec 31, 2024 | $1.85B | -5.3% |
| FY2023 | Dec 31, 2023 | $1.95B | -0.8% |
| FY2022 | Dec 31, 2022 | $1.96B | +32.4% |
| FY2021 | Dec 31, 2021 | $1.48B | +24.3% |
| FY2020 | Dec 31, 2020 | $1.19B | -21.2% |
| FY2019 | Dec 31, 2019 | $1.51B | +2.5% |
| FY2018 | Dec 31, 2018 | $1.48B | +13.0% |
| FY2017 | Dec 31, 2017 | $1.31B | +47.9% |
| FY2016 | Dec 31, 2016 | $883.40M | -12.7% |
| FY2015 | Dec 31, 2015 | $1.01B | +5.3% |
| FY2014 | Dec 31, 2014 | $960.90M | +17.4% |
| FY2013 | Dec 31, 2013 | $818.80M | +5.5% |
| FY2012 | Dec 31, 2012 | $776.40M | +0.3% |
| FY2011 | Dec 31, 2011 | $774.40M | +13.3% |
| FY2010 | Dec 31, 2010 | $683.20M | +14.2% |
| FY2009 | Dec 31, 2009 | $598.50M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $491.40M | +11.8% |
| Q1 FY2026 | Mar 31, 2026 | $453.20M | +2.8% |
| Q4 FY2025 | Dec 31, 2025 | $455.60M | -2.4% |
| Q3 FY2025 | Sep 30, 2025 | $441.90M | -0.3% |
| Q2 FY2025 | Jun 30, 2025 | $439.70M | +1.1% |
| Q1 FY2025 | Mar 31, 2025 | $440.80M | -11.9% |
| Q4 FY2024 | Dec 31, 2024 | $466.80M | -5.6% |
| Q3 FY2024 | Sep 30, 2024 | $443.40M | -4.5% |
| Q2 FY2024 | Jun 30, 2024 | $435.00M | -9.5% |
| Q1 FY2024 | Mar 31, 2024 | $500.20M | -1.8% |
| Q4 FY2023 | Dec 31, 2023 | $494.70M | -3.1% |
| Q3 FY2023 | Sep 30, 2023 | $464.10M | -9.5% |
| Q2 FY2023 | Jun 30, 2023 | $480.40M | +2.7% |
| Q1 FY2023 | Mar 31, 2023 | $509.60M | +7.9% |
| Q4 FY2022 | Dec 31, 2022 | $510.70M | +23.6% |
| Q3 FY2022 | Sep 30, 2022 | $513.00M | +36.4% |
| Q2 FY2022 | Jun 30, 2022 | $467.60M | +31.9% |
| Q1 FY2022 | Mar 31, 2022 | $472.40M | +39.1% |
| Q4 FY2021 | Dec 31, 2021 | $413.20M | +32.9% |
| Q3 FY2021 | Sep 30, 2021 | $376.10M | +41.9% |
| Q2 FY2021 | Jun 30, 2021 | $354.50M | +44.8% |
| Q1 FY2021 | Mar 31, 2021 | $339.60M | -8.8% |
| Q4 FY2020 | Dec 31, 2020 | $310.80M | -20.5% |
| Q3 FY2020 | Sep 30, 2020 | $265.10M | -28.7% |
| Q2 FY2020 | Jun 30, 2020 | $244.90M | -32.4% |
| Q1 FY2020 | Mar 31, 2020 | $372.30M | -4.1% |
| Q4 FY2019 | Dec 31, 2019 | $390.70M | -1.1% |
| Q3 FY2019 | Sep 30, 2019 | $371.90M | +2.4% |
| Q2 FY2019 | Jun 30, 2019 | $362.40M | +1.2% |
| Q1 FY2019 | Mar 31, 2019 | $388.30M | +7.7% |
| Q4 FY2018 | Dec 31, 2018 | $395.00M | +11.6% |
| Q3 FY2018 | Sep 30, 2018 | $363.10M | +9.2% |
| Q2 FY2018 | Jun 30, 2018 | $358.10M | +9.7% |
| Q1 FY2018 | Mar 31, 2018 | $360.70M | +22.6% |
| Q4 FY2017 | Dec 31, 2017 | $353.80M | +48.8% |
| Q3 FY2017 | Sep 30, 2017 | $332.40M | +61.8% |
| Q2 FY2017 | Jun 30, 2017 | $326.30M | – |
| Q1 FY2017 | Mar 31, 2017 | $294.30M | – |
| Q4 FY2016 | Dec 31, 2016 | $237.80M | – |
| Q3 FY2016 | Sep 30, 2016 | $205.50M | – |
See a number that looks wrong?